The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon

被引：6

作者：

Cooksley, G ^{[1
]}

机构：

[1] Royal Brisbane Hosp Fdn, Clin Res Ctr, Brisbane, Qld, Australia

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 39卷

关键词：

D O I：

10.1016/S0168-8278(03)00327-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S143 / S145

页数：3

共 16 条

[1] Peginterferon α-2a (40 kDa):: an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B [J].

Cooksley, WGE ;

Piratvisuth, T ;

Lee, SD ;

Mahachai, V ;

Chao, YC ;

Tanwandee, T ;

Chutaputti, A ;

Chang, WY ;

Zahm, FE ;

Pluck, N .

JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) :298-305

[2]

COOKSLEY WGE, 2001, AM ASS STUD LIV DIS

[3]

COOKSLEY WGE, 2002, EUR ASS STUD LIV MAD

[4] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[5]

Ghany MG, 2000, HEPATOLOGY, V32, p376A, DOI 10.1053/jhep.2000.17912

[6] EFFECT OF HUMAN LEUKOCYTE INTERFERON ON HEPATITIS B VIRUS-INFECTION IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS [J].

GREENBERG, HB ;

POLLARD, RB ;

LUTWICK, LI ;

GREGORY, PB ;

ROBINSON, WS ;

MERIGAN, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (10) :517-522

[7] Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis [J].

Heathcote, EJ ;

Shiffman, ML ;

Cooksley, WGE ;

Dusheiko, GM ;

Lee, SS ;

Balart, L ;

Reindollar, R ;

Reddy, RK ;

Wright, TL ;

Lin, A ;

Hoffman, J ;

De Pamphilis, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) :1673-1680

[8] A one-year trial of lamivudine for chronic hepatitis B [J].

Lai, CL ;

Chien, RN ;

Leung, NWY ;

Chang, TT ;

Guan, R ;

Tai, DI ;

Ng, KY ;

Wu, PC ;

Dent, JC ;

Barber, J ;

Stephenson, SL ;

Gray, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :61-68

[9] Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy [J].

Liaw, YF ;

Chien, RN ;

Yeh, CT ;

Tsai, SL ;

Chu, CM .

HEPATOLOGY, 1999, 30 (02) :567-572

[10] A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C [J].

Lindsay, KL ;

Trepo, C ;

Heintges, T ;

Shiffman, ML ;

Gordon, SC ;

Hoefs, JC ;

Schiff, ER ;

Goodman, ZD ;

Laughlin, M ;

Yao, RJ ;

Albrecht, JK .

HEPATOLOGY, 2001, 34 (02) :395-403

← 1 2 →